The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study
- PMID: 24566903
- DOI: 10.1007/s00417-014-2599-1
The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study
Abstract
Background: To evaluate the efficacy of autologous serum (AS) eye drops for the symptomatic relief of severe dry eye syndrome (DES), as compared to conventional preservative-free artificial tears (PFAT).
Methods: This prospective double-blind randomized crossover study used the Ocular Surface Disease Index (OSDI), tear film break-up time (TBUT), Schirmer's Test, and OXFORD Scale at baseline and after each of two 1-month treatment periods to measure the effect of 20 % diluted AS eye drops vs. PFAT in 20 consecutive severe DES patients that were refractory to conventional treatment.
Results: The study included 20 (18 female and two male) severe DES patients (40 eyes). Significantly higher TBUT (P < 0.001, Wilcoxon signed-rank test) and a greater decrease in OSDI score (55.18 % decrease in the AS treatment group vs. 19.50 % decrease in the PFAT treatment group) (P < 0.001, Student's paired samples t-test) were observed in the AS treatment group after 1 month of treatment. There wasn't a significant difference in Schirmer's test and OXFORD conjunctival and corneal vital dying grading scores between the two treatment groups after 1 month of treatment (P > 0.05 [Mann-Whitney U test]).
Conclusions: AS eye drops were more effective than conventional eye drops for improving tear film stability and subjective comfort in patients with severe DES.
Similar articles
-
Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.Curr Eye Res. 2012 Aug;37(8):684-8. doi: 10.3109/02713683.2012.674609. Epub 2012 Jun 6. Curr Eye Res. 2012. PMID: 22670856 Clinical Trial.
-
Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy.Curr Eye Res. 2017 Jun;42(6):827-831. doi: 10.1080/02713683.2016.1255758. Epub 2017 Jan 31. Curr Eye Res. 2017. PMID: 28139163 Clinical Trial.
-
Efficacy and Safety of Sodium Hyaluronate/chondroitin Sulfate Preservative-free Ophthalmic Solution in the Treatment of Dry Eye: A Clinical Trial.Curr Eye Res. 2021 Jul;46(7):919-929. doi: 10.1080/02713683.2020.1849733. Epub 2020 Dec 8. Curr Eye Res. 2021. PMID: 33289602 Clinical Trial.
-
Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Ophthalmic Res. 2020;63(5):443-451. doi: 10.1159/000505630. Epub 2019 Dec 30. Ophthalmic Res. 2020. PMID: 31884498
-
Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.Blood Transfus. 2019 May;17(3):200-209. doi: 10.2450/2019.0080-19. Blood Transfus. 2019. PMID: 31246562 Free PMC article.
Cited by
-
Application of Novel Drugs for Corneal Cell Regeneration.J Ophthalmol. 2018 May 2;2018:1215868. doi: 10.1155/2018/1215868. eCollection 2018. J Ophthalmol. 2018. PMID: 29854423 Free PMC article. Review.
-
The Comparison between the Composition of 100% Autologous Serum and 100% Platelet-Rich Plasma Eye Drops and Their Impact on the Treatment Effectiveness of Dry Eye Disease in Primary Sjogren Syndrome.J Clin Med. 2023 Apr 25;12(9):3126. doi: 10.3390/jcm12093126. J Clin Med. 2023. PMID: 37176566 Free PMC article.
-
Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro.Int J Ophthalmol. 2017 Jun 18;10(6):908-913. doi: 10.18240/ijo.2017.06.12. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28730081 Free PMC article.
-
The use of autologous serum eye drops for the treatment of ocular surface disorders.Eur J Hosp Pharm. 2019 Nov;26(6):314-317. doi: 10.1136/ejhpharm-2018-001527. Epub 2018 May 4. Eur J Hosp Pharm. 2019. PMID: 31798853 Free PMC article.
-
A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel.Clin Ophthalmol. 2022 Apr 28;16:1331-1355. doi: 10.2147/OPTH.S351898. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35520107 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials